NDC 72162-1625-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1625
- Requested NDC
- 72162-1625-01
- Package NDCs from labels
- 72162-1625-0, 72162-1625-1, 72162-1625-3, 72162-1625-4, 72162-1625-5, 72162-1625-6, 72162-1625-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1625-0 | Spironolactone and Hydrochlorothiazide | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 107 | |
| 72162-1625-1 | Spironolactone and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 107 | |
| 72162-1625-3 | Spironolactone and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 107 | |
| 72162-1625-4 | Spironolactone and Hydrochlorothiazide | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 107 | |
| 72162-1625-5 | Spironolactone and Hydrochlorothiazide | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 107 | |
| 72162-1625-6 | Spironolactone and Hydrochlorothiazide | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 107 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1625 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 103 | Current NDC, 6 package rows | 20240920_b3228678-7992-4148-b4ab-aa0d8b1b8570.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1625-0 | EA - Each | 72162-1625 | 80e4d34b-73b6-43b6-b701-b03b0bfdba2d | 1 | 2024-10-04 |
| 72162-1625-1 | EA - Each | 72162-1625 | f1befe5c-8e07-47f8-85ed-e1beab4b3be1 | 1 | 2024-01-04 |
| 72162-1625-3 | EA - Each | 72162-1625 | 23581e8f-7626-4465-96cf-fc626ba87093 | 1 | 2024-01-04 |
| 72162-1625-4 | EA - Each | 72162-1625 | 85002e63-3d8d-4018-8a71-957594fac2dd | 1 | 2025-08-11 |
| 72162-1625-5 | EA - Each | 72162-1625 | 32249ef1-7f3d-4710-999f-8fd434d1cc35 | 1 | 2024-03-12 |
| 72162-1625-6 | EA - Each | 72162-1625 | bd5d6bc5-d262-42a8-916f-d7d7d91f9763 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | ETJ7Z6XBU4 |
| Spironolactone | SPIRONOLACTONE | Safecor Health LLC | 7057c090-67c2-414c-9077-bed18ad4b0b3 | 2026-07-01 | Warnings, Adverse reactions | 27O7W4T232 |
| Curewell Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | RMT HEALTH LLC | 55903043-2a1d-0525-e063-6394a90ae182 | 2026-07-01 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | Aarkish Pharmaceuticals NJ Inc. | faca8f3e-d9eb-44c5-93ab-f59ed1c0f56f | 2026-07-01 | Warnings | F05Q2T2JA0 |
| Spironolactone | SPIRONOLACTONE | REMEDYREPACK INC. | 6518ba72-89e4-4f2f-b334-9ef759b696f8 | 2026-06-30 | Warnings, Adverse reactions | 27O7W4T232 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | e1aa9682-b1ad-4a22-e053-2a95a90a0e2f | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ENEMEEZ | DOCUSATE SODIUM | Quest Products, LLC | 0b06445d-0839-497e-bdff-e0fe224a7738 | 2026-06-30 | Warnings | F05Q2T2JA0 |
| ENEMEEZ Plus | DOCUSATE SODIUM AND BENZOCAINE | Quest Products, LLC | 1670ca59-7275-4ac6-bef4-674a7b24c7b3 | 2026-06-30 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | c1f588d0-4600-4b97-b2d3-2c08ac351e07 | 2026-06-30 | Warnings | F05Q2T2JA0 |
| Bambusa Stannum | BAMBUSA STANNUM | Uriel Pharmacy Inc. | a0d4d0ac-e2d2-4381-8f93-e41719521859 | 2026-06-30 | Warnings | ETJ7Z6XBU4 |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Safecor Health LLC | 6fa96947-f4d8-4ca4-98fd-a2c123310d83 | 2026-06-29 | Warnings, Adverse reactions | 198224 0J48LPH2TH 27O7W4T232 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 3857ac53-0435-4d68-8066-c22291414889 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | be7cab51-ce7e-465d-95db-083e69288cfd | 2026-06-25 | Warnings | F05Q2T2JA0 |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 0de72197-607f-ef0a-e063-6394a90a8949 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 868b1442-c412-4ee8-9798-f2408cd2249a | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 191d5710-7b8a-0b61-e063-6394a90afd41 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 408e797a-2cf3-4ee6-9f9b-179a8cf3d799 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unit Dose Solutions, Inc. | 54f027ea-0a6e-7920-e063-6394a90ab6ae | 2026-06-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 03b11335-2e88-2f7b-e063-6394a90afe2a | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | eac57b4c-e79b-8d35-e053-2a95a90a9d25 | 2026-06-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.